NYSE
AHR
Last Price
US $57.78
KEY FIGURES
MKT CAP
$13.4B
EPS
TTM$0.44
EPS Growth (1Y)
-244.83%
PEG
TTM1.95x
P/E
TTM130.05x
P/S
TTM4.69x
YIELD
1.7%
Profit margin
Current Ratio
Capital Returns
2.40%
Return on equity
ROIC: 2.40%
Valuation History
119.5X
Price to Earnings
EV/EBITDA: 30.5X
Cash flow
Profit margin
GROWTH (5Y CAGR)
Revenue
13.79%
EBITDA
17.24%
Cash flow
12.79%
Base Cash Flow Valuation (DCF)
Fair Value
Market $57.78
-68.26%
Default assumptions
Base EBITDA Valuation
Fair Value
Market $57.78
-90.19%
Default assumptions
Base valuations use default assumptions. Customize in the Valuator.
Valuation
Financial
Performance
Cash flow to debt coverage
American Healthcare REIT, Inc. cash flow to debt ratio of 17.46% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.
Free cash flow growth
American Healthcare REIT, Inc.'s free cash flow has increased 97.13% from $84.15M last year to $165.88M, signaling increasing performance
Debt-to-equity ratio
American Healthcare REIT, Inc.'s debt to equity ratio is 0.00, which means that the company's assets are healthy financed, signaling financial stability.
Debt-to-equity trend
American Healthcare REIT, Inc.'s debt has decreased relative to shareholder equity from 0.83 last year to 0.00 today, signaling strengthened financials
Net debt to EBITDA
American Healthcare REIT, Inc. has a net debt to EBITDA ratio of 4.37x, which exceeds the 3.00x threshold, indicating high leverage and potential financial risk
Interest coverage
American Healthcare REIT, Inc.'s interest coverage ratio of 2.31 indicates that earnings with margin can cover interest payments on company debt
Profit margin growth
American Healthcare REIT, Inc.'s profit margin was -1.83% last year and is 3.61% this year, signaling increasing performance
Current ratio
American Healthcare REIT, Inc.'s short-term liabilities of $867.50M exceed its short-term assets of $319.15M, signaling financial risk
Return on assets
American Healthcare REIT, Inc.'s return on assets of 1.27% is lower than the 5.00% threshold, indicating inefficient asset utilization
Return on equity
American Healthcare REIT, Inc.'s return on equity of 2.40%, is lower than 15.00%, indicating bad performance
Earnings quality
American Healthcare REIT, Inc.'s operating cash flow exceeds its net income, indicating high-quality earnings backed by actual cash generation
Earnings stability
American Healthcare REIT, Inc. has insufficient public price history to evaluate earnings stability.
Positive free cash flow
American Healthcare REIT, Inc. has positive free cash flow, indicating the company generates cash after capital expenditures
Free cash flow yield
American Healthcare REIT, Inc. has a free cash flow yield of 1.32%, which is below the 2.00% threshold, indicating limited cash return relative to market value
Earnings growth
American Healthcare REIT, Inc.'s yearly earnings has increased 284.61% since last year from $-37.81M to $69.81M, signaling increasing performance
Revenue growth
American Healthcare REIT, Inc.'s yearly revenue has increased 9.15% since last year from $2.07B to $2.26B, signaling increasing performance
Return on invested capital
ROIC 12.93% (Source: FMP key-metrics). At or above the 10% threshold. Score: 2 of 2. The company is generating returns above the upper end of the typical US weighted-average cost of capital range under this definition of invested capital.
3-year revenue CAGR
American Healthcare REIT, Inc.'s 3-year revenue CAGR of 11.80% is positive, indicating growing revenue over the past 3 years
Revenue consistency
American Healthcare REIT, Inc. has insufficient public price history to evaluate revenue consistency.
Return on equity consistency
American Healthcare REIT, Inc. has insufficient public price history to evaluate ROE consistency.
Base Cash Flow Valuation (DCF)
American Healthcare REIT, Inc. is overvalued relative to its fair value price of 18.34 based on Base Cash Flow Valuation (DCF) model
Earnings yield (TTM)
American Healthcare REIT, Inc. has an earnings yield of 0.77%, which is below the 4.00% threshold, indicating the stock may be expensive relative to its earnings
Base EBITDA Valuation
American Healthcare REIT, Inc. is overvalued relative to its fair value price of 5.67 based on Base EBITDA Valuation model
EV/EBITDA (FY)
American Healthcare REIT, Inc. has an EV/EBITDA ratio of 39.41x, which exceeds the 20.00x threshold, indicating the stock may be overvalued relative to its operating earnings
PEG ratio (TTM/FY)
American Healthcare REIT, Inc. has a PEG-ratio over 1 which is considered overvalued
Price-to-book ratio (FY)
American Healthcare REIT, Inc. has a price-to-book ratio of 2.22x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value
Price-to-sales ratio (TTM)
American Healthcare REIT, Inc. has a price-to-sales ratio of 4.70x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue